Cooper Companies (NASDAQ:COO) Stock Rating Upgraded by William Blair

Cooper Companies (NASDAQ:COO) was upgraded by equities researchers at William Blair to a “strong-buy” rating in a research report issued on Friday,Zacks.com reports.

Other research analysts also recently issued reports about the company. The Goldman Sachs Group reaffirmed a “sell” rating and set a $73.00 target price on shares of Cooper Companies in a research note on Friday, January 9th. Weiss Ratings raised shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, January 12th. Citigroup restated a “neutral” rating and set a $88.00 price objective (up from $72.00) on shares of Cooper Companies in a research report on Monday, December 8th. Needham & Company LLC reiterated a “buy” rating and issued a $100.00 target price (up previously from $94.00) on shares of Cooper Companies in a research report on Friday, December 5th. Finally, Robert W. Baird boosted their target price on shares of Cooper Companies from $85.00 to $98.00 and gave the stock an “outperform” rating in a research note on Friday, December 5th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $90.85.

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $81.38 on Friday. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.89 and a quick ratio of 1.13. The stock has a market capitalization of $15.95 billion, a price-to-earnings ratio of 43.29, a PEG ratio of 2.29 and a beta of 1.03. The firm’s 50 day simple moving average is $81.07 and its 200-day simple moving average is $74.25. Cooper Companies has a 12 month low of $61.78 and a 12 month high of $97.95.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, December 4th. The medical device company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.11 by $0.04. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The company had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same quarter last year, the business earned $1.04 earnings per share. The firm’s revenue was up 4.6% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Analysts expect that Cooper Companies will post 3.98 EPS for the current year.

Insiders Place Their Bets

In other news, Director Lawrence Erik Kurzius acquired 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, December 17th. The stock was purchased at an average cost of $82.50 per share, for a total transaction of $165,000.00. Following the completion of the transaction, the director owned 7,777 shares in the company, valued at approximately $641,602.50. This trade represents a 34.62% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Maria Rivas bought 1,000 shares of Cooper Companies stock in a transaction on Thursday, December 18th. The shares were purchased at an average cost of $82.13 per share, for a total transaction of $82,130.00. Following the completion of the purchase, the director directly owned 11,141 shares of the company’s stock, valued at $915,010.33. This trade represents a 9.86% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last three months, insiders bought 16,014 shares of company stock worth $1,304,416. 1.98% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in COO. Bell Investment Advisors Inc boosted its holdings in Cooper Companies by 106.3% during the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock valued at $29,000 after acquiring an additional 219 shares during the period. J.Safra Asset Management Corp boosted its stake in shares of Cooper Companies by 204.8% in the second quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock valued at $36,000 after purchasing an additional 340 shares during the period. CYBER HORNET ETFs LLC acquired a new position in shares of Cooper Companies in the second quarter valued at approximately $36,000. True Wealth Design LLC increased its stake in Cooper Companies by 484.8% during the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after buying an additional 383 shares during the period. Finally, Cromwell Holdings LLC lifted its holdings in Cooper Companies by 128.8% during the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after buying an additional 273 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.